نتایج جستجو برای: ox40

تعداد نتایج: 901  

Journal: :Journal of immunology 2008
Wei Duan Takanori So Michael Croft

Respiratory exposure to allergens can lead to airway tolerance. Factors that antagonize tolerance mechanisms in the lung might result in susceptibility to diseases such as asthma. We show that inhalation of endotoxin/LPS with Ag prevented airway tolerance and abolished protection from T cell-driven asthmatic lung inflammation. Under conditions leading to tolerance, adaptive Ag-specific CD4(+)Fo...

2003
Takeshi Tsuchiya Koichi Ohshima Kennosuke Karube Takahiro Yamaguchi Hiroaki Suefuji Makoto Hamasaki Chika Kawasaki Junji Suzumiya Masao Tomonaga Masahiro Kikuchi

A new World Health Organization classification was recently proposed. However, classification of peripheral T-cell lymphomas remains to be clarified. Particularly, unspecified type was considered as a heterogeneous category. Here we studied the expressions of chemokine receptors, Th1-associated CXCR3 and CCR5 and Th2-associated marker ST2(L), and activated T-cell receptor OX40/CD134 in 185 pati...

2015
Dajana Reuter Martin S. Staege Caspar D. Kühnöl Jürgen Föll

Interleukin-2 (IL-2) transgenic Ewing sarcoma cells can induce tumor specific T and NK cell responses and reduce tumor growth in vivo and in vitro. Nevertheless, the efficiency of this stimulation is not high enough to inhibit tumor growth completely. In addition to recognition of the cognate antigen, optimal T-cell stimulation requires signals from so-called co-stimulatory molecules. Several m...

Journal: :Cancer research 2004
Sita Andarini Toshiaki Kikuchi Mio Nukiwa Prasenohadi Pradono Takuji Suzuki Shinya Ohkouchi Akira Inoue Makoto Maemondo Naoto Ishii Yasuo Saijo Kazuo Sugamura Toshihiro Nukiwa

OX40 ligand (OX40L), the ligand for OX40 on activated CD4+ T cells, has adjuvant properties for establishing effective T-cell immunity, a potent effector arm of the immune system against cancer. The hypothesis of this study is that in vivo genetic engineering of tumor cells to express OX40L will stimulate tumor-specific T cells by the OX40L-OX40 engagement, leading to an induction of systemic a...

Journal: :Journal of immunology 2006
Susumu Nakae Hajime Suto Motoyasu Iikura Maki Kakurai Jonathon D Sedgwick Mindy Tsai Stephen J Galli

We recently reported that mast cells stimulated via FcepsilonRI aggregation can enhance T cell activation by a TNF-dependent mechanism. However, the molecular mechanisms responsible for such IgE-, Ag- (Ag-), and mast cell-dependent enhancement of T cell activation remain unknown. In this study we showed that mouse bone marrow-derived cultured mast cells express various costimulatory molecules, ...

Journal: :Journal of immunology 2004
Stephanie K Lathrop Cortny A Huddleston Per A Dullforce Megan J Montfort Andrew D Weinberg David C Parker

To study mechanisms of peripheral self-tolerance, we injected small numbers of naive CD4(+) TCR-transgenic T cells into mice expressing the MHC/peptide ligand under the control of an MHC class II promoter. The donor T cells expand rapidly to very large numbers, acquire memory markers, and go out into tissues, but the animals remain healthy, and the accumulated T cells are profoundly anergic to ...

Journal: :Cancer immunology research 2018
Zuzana Berrong Mikayel Mkrtichyan Shamim Ahmad Mason Webb Eslam Mohamed Grigori Okoev Adelaida Matevosyan Rajeev Shrimali Rasha Abu Eid Scott Hammond John E Janik Samir N Khleif

Although an immune response to tumors may be generated using vaccines, so far, this approach has only shown minimal clinical success. This is attributed to the tendency of cancer to escape immune surveillance via multiple immune suppressive mechanisms. Successful cancer immunotherapy requires targeting these inhibitory mechanisms along with enhancement of antigen-specific immune responses to pr...

2016
Kristina H Young Jason R Baird Talicia Savage Benjamin Cottam David Friedman Shelly Bambina David J Messenheimer Bernard Fox Pippa Newell Keith S Bahjat Michael J Gough Marka R Crittenden

The anecdotal reports of promising results seen with immunotherapy and radiation in advanced malignancies have prompted several trials combining immunotherapy and radiation. However, the ideal timing of immunotherapy with radiation has not been clarified. Tumor bearing mice were treated with 20Gy radiation delivered only to the tumor combined with either anti-CTLA4 antibody or anti-OX40 agonist...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید